Evidence map›Paper›PMID 35527351›Full record

ArticleHealth economics2022

On the demand for telemedicine: Evidence from the COVID-19 pandemic.

Matias Busso, Maria P Gonzalez, Carlos Scartascini

Abstract read
In one paragraph

Article in Health economics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Comparing the trends of MBS telepsychiatry and consultant physician telehealth services from 2017 to 2022: A retrospective study.Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Telemedicine Use and the Perceived Risk of COVID-19: Patient Experience.International journal of environmental research and public health · 2023
    Article
  16. Article
  17. Article
  18. Telemedicine in the COVID-19 Era: A Narrative Review Based on Current Evidence.International journal of environmental research and public health · 2022
    Review
  19. Article
  20. Technology's Impact on Nurse Manager Practices.Nursing administration quarterly
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Matias BussoResearch Department, Inter-American Development Bank, Washington, District of Columbia, USA.ORCID 0000-0001-5632-9129
Maria P GonzalezResearch Department, Inter-American Development Bank, Washington, District of Columbia, USA.
Carlos ScartasciniResearch Department, Inter-American Development Bank, Washington, District of Columbia, USA.ORCID 0000-0001-7031-3983

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Telemedicine can expand access to health care at relatively low cost. Historically, however, demand for telemedicine has remained low. Using administrative records and a difference-in-differences methodology, we estimate the change in demand for telemedicine experienced after the onset of the COVID-19 epidemic and the imposition of mobility restrictions. We find that the number of telemedicine calls made during the pandemic increased by 230 percent compared to the pre-pandemic period. The effects were mostly driven by older individuals with preexisting conditions who used the service for internal medicine consultations. The demand for telemedicine remained relatively high even after mobility restrictions were relaxed, which is consistent with telemedicine being an "experience good." These results are a proof of concept for policy makers to use such relatively low-cost medical consultations, made possible by new technologies, to provide needed expansion of access to health care.

Indexed as

COVID-19TelemedicineHumansPandemicsReferral and ConsultationSARS-CoV-2ArgentinacoronavirusCOVID-19health care demandtelemedicine

Identifiers

PMID35527351
PMCPMC9324159

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.